Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-21-030131

Options or other derivatives

  • CFO and CBO acquired 360,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Humer Kristian CFO and CBO 2021-07-26 Grant or award · Stock Option (Right to Buy) +360,000 360,000 D
Loading xslF345X03/doc4.xml…